Insmed Inc (INSM)
70.53
-0.06
(-0.08%)
USD |
NASDAQ |
Dec 24, 16:00
Insmed Cash from Investing (Quarterly): -1.003B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -30.25M |
| Cytokinetics Inc | -45.05M |
| Amicus Therapeutics Inc | 34.27M |
| Collegium Pharmaceutical Inc | -248.96M |
| Krystal Biotech Inc | -34.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -180.92M |
| Cash from Financing (Quarterly) | 397.20M |
| Free Cash Flow | -636.03M |
| Free Cash Flow Per Share (Quarterly) | -1.063 |
| Free Cash Flow to Equity (Quarterly) | 31.84M |
| Free Cash Flow to Firm (Quarterly) | -163.45M |
| Free Cash Flow Yield | -5.80% |